
|Videos|July 24, 2017
Hydroxyurea Resistant Polycythemia Vera
Hydroxyurea Resistant Polycythemia Vera
Advertisement
January 2015
- A 39-year-old male presents with headache and weight loss
- He is a 2-pack a day smoker
- PMH includes type 2 diabetes, moderately controlled on medication; newly-diagnosed hypertension
- Physical exam: BP, 176/94, otherwise unremarkable
- Laboratory values:
- Hb; 233 g/L
- Hct; 68.9%;
- Mean corpusc. vol.; 81 fL
- Leukocytes; 4.4 × 109/L
- Platelets; 145 × 109/L
- Bone marrow biopsy;
- MF-3 fibrosis and megakaryocytic hyperplasia with atypia
- Normal karyotype
- JAK2-positive
- Patient was started on phlebotomy as needed and aspirin
April 2015
- Patient had 3 phlebotomies in the last 3 months.
- He reported increasing dizziness, headaches and nausea
- He was continued on phlebotomy as needed; aspirin was continued
- Patient was started on Hydroxyurea 1000 mg daily
July 2015
- Patient comes back 3 months later, he has had 2 phlebotomies
- Hydroxyurea is increased to 1500 mg
October 2015
- Patient returns 3 months later with pruritus, still requiring phlebotomy
- He is started on hydroxyurea 2000 mg daily
January 2016
- The patient has had 2 phlebotomies since his last visit; he reports abdominal fullness
- He also has restless legs and is complaining that food tastes funny
- Spleen is palpable 7 cm below costal margin
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5








































